Oncospace
Baltimore, US · Founded 2018 · Maryland corporation
Biotech
Founders & leadership
PS
Praveen SinhaNamed on SEC filing
DR
Daniel RocheNamed on SEC filing
TM
Todd McNuttNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$900K disclosed across 1 round · 2019
▶$900KraisedMay 2019 · 11 investors · BiotechnologyRule 506(b)
▶$900KraisedMay 2019 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Praveen SinhaExecutive Officer, Director
- Daniel RocheDirector
- Todd McNuttExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $900K
- First sale
- Mar 2019
- Incorporated
- Corporation, Maryland, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 4 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $399.9K |
| National Science Foundation | Phase II | 2021 | $1M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $520.9K |
| National Science Foundation | Phase I | 2019 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- How much funding has Oncospace raised?
- Oncospace has disclosed $900K raised across 1 round.
- Where is Oncospace headquartered?
- Oncospace is headquartered in Baltimore, US.